BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23958880)

  • 1. New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
    Monderer D; Luseau A; Bellec A; David E; Ponsolle S; Saiagh S; Bercegeay S; Piloquet P; Denis MG; Lodé L; Rédini F; Biger M; Heymann D; Heymann MF; Le Bot R; Gouin F; Blanchard F
    Lab Invest; 2013 Oct; 93(10):1100-14. PubMed ID: 23958880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone.
    van Oosterwijk JG; de Jong D; van Ruler MA; Hogendoorn PC; Dijkstra PD; van Rijswijk CS; Machado I; Llombart-Bosch A; Szuhai K; Bovée JV
    BMC Cancer; 2012 Aug; 12():375. PubMed ID: 22928481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.
    Peterse EFP; Niessen B; Addie RD; de Jong Y; Cleven AHG; Kruisselbrink AB; van den Akker BEWM; Molenaar RJ; Cleton-Jansen AM; Bovée JVMG
    Br J Cancer; 2018 Apr; 118(8):1074-1083. PubMed ID: 29576625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing.
    van Oosterwijk JG; Plass JR; Meijer D; Que I; Karperien M; Bovée JV
    Virchows Arch; 2015 Jan; 466(1):101-9. PubMed ID: 25331842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Profiling Identifies Association of
    Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
    Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells.
    van Oosterwijk JG; van Ruler MA; Briaire-de Bruijn IH; Herpers B; Gelderblom H; van de Water B; Bovée JV
    Br J Cancer; 2013 Sep; 109(5):1214-22. PubMed ID: 23922104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research?
    Ma R; Mandell J; Lu F; Heim T; Schoedel K; Duensing A; Watters RJ; Weiss KR
    Clin Orthop Relat Res; 2021 Mar; 479(3):477-490. PubMed ID: 32469486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma.
    Roche ME; Lin Z; Whitaker-Menezes D; Zhan T; Szuhai K; Bovee JVMG; Abraham JA; Jiang W; Martinez-Outschoorn U; Basu-Mallick A
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165962. PubMed ID: 32920118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.
    Tarpey PS; Behjati S; Cooke SL; Van Loo P; Wedge DC; Pillay N; Marshall J; O'Meara S; Davies H; Nik-Zainal S; Beare D; Butler A; Gamble J; Hardy C; Hinton J; Jia MM; Jayakumar A; Jones D; Latimer C; Maddison M; Martin S; McLaren S; Menzies A; Mudie L; Raine K; Teague JW; Tubio JM; Halai D; Tirabosco R; Amary F; Campbell PJ; Stratton MR; Flanagan AM; Futreal PA
    Nat Genet; 2013 Aug; 45(8):923-6. PubMed ID: 23770606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
    Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
    Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy.
    Zhang YX; van Oosterwijk JG; Sicinska E; Moss S; Remillard SP; van Wezel T; Bühnemann C; Hassan AB; Demetri GD; Bovée JV; Wagner AJ
    Clin Cancer Res; 2013 Jul; 19(14):3796-807. PubMed ID: 23714727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
    Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
    Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model.
    Palubeckaitė I; Venneker S; van den Akker BEWM; Briaire-de Bruijn IH; Boveé JVMG
    Clin Orthop Relat Res; 2023 Mar; 481(3):608-619. PubMed ID: 36729612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
    Joseph NM; McGill KC; Horvai AE
    Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.
    Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production.
    Calabuig-Fariñas S; Benso RG; Szuhai K; Machado I; López-Guerrero JA; de Jong D; Peydró A; San Miguel T; Navarro L; Pellín A; Llombart-Bosch A
    Pathol Oncol Res; 2012 Oct; 18(4):793-802. PubMed ID: 22350793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.
    Tinoco G; Wilky BA; Paz-Mejia A; Rosenberg A; Trent JC
    Am Soc Clin Oncol Educ Book; 2015; ():e648-55. PubMed ID: 25993236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression.
    Kim H; Cho Y; Kim HS; Kang D; Cheon D; Kim YJ; Chang MJ; Lee KM; Chang CB; Kang SB; Kang HG; Kim JH
    Nat Commun; 2020 Oct; 11(1):5023. PubMed ID: 33024108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel benzofuran derivative, ACDB, induces apoptosis of human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.
    Su CM; Chen CY; Lu T; Sun Y; Li W; Huang YL; Tsai CH; Chang CS; Tang CH
    Oncotarget; 2016 Dec; 7(50):83530-83543. PubMed ID: 27835579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.
    Boeuf S; Kunz P; Hennig T; Lehner B; Hogendoorn P; Bovée J; Richter W
    J Pathol; 2008 Oct; 216(2):158-66. PubMed ID: 18702172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.